The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Klotho Neurosciences's current ratio for the quarter that ended in Sep. 2025 was 83.59.
Klotho Neurosciences has a current ratio of 83.59. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Klotho Neurosciences's Current Ratio or its related term are showing as below:
KLTO'
s Current Ratio Range Over the Past 10 Years
Min: 0.03 Med: 0.29 Max: 135.65
Current: 83.59
During the past 4 years, Klotho Neurosciences's highest Current Ratio was 135.65. The lowest was 0.03. And the median was 0.29.
KLTO's Current Ratio is not ranked
in the Biotechnology industry.
Industry Median: 3.885
vs KLTO: 83.59
Klotho Neurosciences (NAS:KLTO) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Klotho Neurosciences Current Ratio Related Terms
Klotho Neurosciences Current Ratio Historical Data
* Premium members only.
The historical data trend for Klotho Neurosciences's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KLTO vs KTTA, JUNS, ZEOX: Current Ratio Comparison
For the Biotechnology subindustry, Klotho Neurosciences's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Klotho Neurosciences Current Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Klotho Neurosciences's Current Ratio distribution charts can be found below:
* The bar in red indicates where Klotho Neurosciences's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Klotho Neurosciences (KLTO) has a Current Ratio of 83.59 as of Sep. 2025. This is 28724% above median its historical median of 0.29. Over the past decade, Klotho Neurosciences' Current Ratio has ranged from 0.03 to 135.65.
Is Klotho Neurosciences' Current Ratio too high?
Klotho Neurosciences' current Current Ratio of 83.59 is 28724% above median its 10-year median of 0.29. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 135.65. The Biotechnology industry median Current Ratio is 3.89. Klotho Neurosciences' value of 83.59 is 2051.6% above this industry median. Overall, Klotho Neurosciences has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Klotho Neurosciences' Current Ratio compare to KTTA and JUNS?
Klotho Neurosciences' Current Ratio of 83.59 can be compared against companies in the Biotechnology industry. The industry median Current Ratio is 3.89. Klotho Neurosciences' value of 83.59 is 2051.6% above this benchmark. Historically, Klotho Neurosciences' own Current Ratio has ranged from 0.03 to 135.65 over the past decade. While the company's 10-year median is 0.29 vs. the industry median of 3.89, Klotho Neurosciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Biotechnology company?
The median Current Ratio among Biotechnology companies is 3.89, based on 1,416 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Klotho Neurosciences's current Current Ratio of 83.59 is 2051.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median Current Ratio is 3.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Klotho Neurosciences's current Current Ratio is 83.59, which is 28724% above median its own 10-year median of 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Klotho Neurosciences stock overvalued right now?
Klotho Neurosciences (KLTO) has a current Current Ratio of 83.59. The current Current Ratio is 83.59, which is 28724% above median its 10-year median of 0.29 and 2051.6% above the Biotechnology industry median of 3.89. Klotho Neurosciences' overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Klotho Neurosciences (KLTO), the current Current Ratio is 83.59 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
22GF Score
Get the complete analysis for KLTO
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KLTO has been successfully added to your 
